Not checkedNot checked for notices yet.
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Jonathan D. Herman, Chuangqi Wang, Carolin Loos and 12 more
Nature Communications · 2021
doi:10.1038/s41467-021-27201-y (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Convalescent plasma (CP) has been trialed as a therapy for SARS-CoV-2 symptoms, but its heterogenous nature precludes uniform outcomes. Here the authors perform deep profiling of CP, as well as plasma of CP recipients before and after transfer, to find CP-mediated, spike/nucleocapsid-focused modulations of humoral responses in the recipient.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.